Wenjuan Tian
No. 255, Dong'An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Interaction between XRCC2 gene polymorphism and abdominal obesity on risk of endometrial carcinoma.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: March 22, 2024
Camrelizumab plus apatinib in patients with advanced or recurrent endometrial cancer after failure of at least one prior systemic therapy (CAP 04): a single-arm phase II trial.
Journal: BMC medicine
Published: March 08, 2024
Tau Aggregation-Dependent Lipid Peroxide Accumulation Driven by the hsa_circ_0001546/14-3-3/CAMK2D/Tau Complex Inhibits Epithelial Ovarian Cancer Peritoneal Metastasis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 22, 2023
Anlotinib in patients with recurrent platinum resistant/refractory ovarian cancer: a prospective, single arm, phase II study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 29, 2023
Safety, tolerability, pharmacokinetics, and immunogenicity of JMB2002-an antibody against COVID-19: a phase 1 clinical trial in healthy Chinese adults.
Journal: BMC infectious diseases
Published: March 09, 2023
The feedback loop of AURKA/DDX5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer.
Journal: Cancer letters
Published: February 19, 2023
Efficacy and safety of apatinib in patients with recurrent uterine malignancy: a prospective, single-center, single-arm, phase 2 study.
Journal: Annals of translational medicine
Published: November 29, 2022
Characterization of hotspot exonuclease domain mutations in the DNA polymerase ϵ gene in endometrial cancer.
Journal: Frontiers in oncology
Published: August 12, 2022
Cancer-Associated Fibroblast-Derived Interleukin-8 Promotes Ovarian Cancer Cell Stemness and Malignancy Through the Notch3-Mediated Signaling.
Journal: Frontiers in cell and developmental biology
Published: March 23, 2021
Promoter Methylation-mediated Silencing of the MiR-192-5p Promotes Endometrial Cancer Progression by Targeting ALX1.
Journal: International journal of medical sciences
Published: February 02, 2021
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: October 10, 2020
A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1/G2 endometrioid endometrial cancer.
Journal: Gynecologic oncology
Published: March 11, 2020
Last Updated: 09/26/2026